Pas de connexion internet — affichage de la version enregistrée de la page.

Tempus AI, Inc.

USUSD
← Vers le screener

Tempus AI, Inc. (US:TEM) — Computer Software: Programming Data Processing. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
tempus.com
Secteur
Technology · Computer Software: Programming Data Processing
Siège social
CHICAGO, United States
PDG
Mr. Eric P. Lefkofsky J.D.
Employés
3 800
Actions en circulation
175.39 M
Flottant
116.3 M
Capitalisation boursière
15.35 Md USD
Initiés
36.77%
Investisseurs institutionnels
59.28%
Secteur d'activité (SIC)
Services-Computer Programming, Data Processing, Etc.
ISIN
US88023B1035
Description

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksTEM principaleUSD70.35 -2.26%actions ordinaires
MI Borsa Italiana (Milan)1TEM secondaireEUR60.55 -5.66%actions ordinaires
MX Mexican Stock ExchangeTEM secondaireMXN1 300 -4.94%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

Aucun versement de dividendes n'a été trouvé (vérifié le 09.10.2026). L'entreprise ne verse probablement pas de dividendes.

Actualités de cette semaine

Pas encore d'actualités du site de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
ARK Investment Managemen…5.71%10.02 M2026-06-30
Blackrock Inc.4.73%8.29 M2026-06-30
BAILLIE GIFFORD & CO4.67%8.19 M2026-06-30
ARK ETF Trust-ARK Innova…3.11%5.46 M2026-08-31
Softbank Group Corporati…3.08%5.41 M2026-06-30
JPMORGAN CHASE & CO2.84%4.99 M2026-06-30
Vanguard Capital Managem…2.84%4.99 M2026-06-30
Vanguard Portfolio Manag…2.8%4.91 M2026-06-30
Sumitomo Mitsui Trust Gr…2.33%4.09 M2026-06-30
Amova Asset Management A…2.33%4.09 M2026-06-30
Goldman Sachs Group Inc2.14%3.76 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.05%3.6 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.48%2.6 M2026-06-30
ARK ETF Trust-ARK Genomi…1.44%2.52 M2026-08-31
VANGUARD WORLD FUND-Vang…1.26%2.2 M2026-05-31
VANGUARD INDEX FUNDS-Van…0.86%1.5 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.67%1.18 M2026-06-30
EntrepreneurShares Serie…0.44%775 1002026-06-30
iShares Trust-iShares Bi…0.44%774 4892026-07-31
Franklin Custodian Funds…0.43%750 0002026-06-30
POLOVIN ANDREW (Officer)≈0.08%138 1402026-08-19
ROGERS JAMES WILLIAM (Ch…≈0.06%106 0242026-08-19
LEONSIS THEODORE J (Dire…≈0.05%88 1802026-05-21
SCHOENHERR THOMAS EDWARD…≈0.05%87 0212026-08-21
PHELPS ERIK J. (Officer)≈0.05%79 8162026-02-19
BARTOLUCCI RYAN M (Offic…≈0.04%67 8662026-08-18
FUKUSHIMA RYAN (Officer)——2026-09-01
KEYWELL BRADLEY A (Forme…——2025-01-17
LEFKOFSKY ERIC PAUL (Chi…——2026-09-22
RED SKY VENTURES L L C (…——2024-12-11